OfloxacinThird Party Manufacturing in India

Ofloxacin works by interfering with the essential enzymes required for bacterial DNA replication, transcription, repair, and recombination.

It specifically targets and inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV. By blocking these crucial enzymes, ofloxacin prevents the unwinding of DNA that is necessary for cell growth and division. This biological effect helps the body rapidly halt the proliferation of susceptible bacteria, leading to the eradication of the infection.

Unlike older classes of antibiotics that may only inhibit bacterial growth, Ofloxacin exerts a rapid bactericidal effect. It is highly effective and well-tolerated for treating a wide array of systemic and localized bacterial infections, offering excellent tissue penetration and a broad spectrum of activity.

Therapeutic Uses

Ofloxacin is prescribed for the treatment of:

• Respiratory Tract Infections: Effective against community-acquired pneumonia and acute bacterial exacerbations of chronic bronchitis.
• Urinary Tract Infections: Treats complicated and uncomplicated UTIs, including cystitis and pyelonephritis.
• Skin and Soft Tissue Infections: Used for resolving infections caused by susceptible Gram-positive and Gram-negative bacteria.
• Pelvic Inflammatory Disease: Frequently utilized as part of combination therapy to treat acute pelvic inflammatory disease.
• Gastrointestinal Infections: Helpful in treating specific bacterial enteritis and traveler's diarrhea.

Why Manufacturers Choose Ofloxacin

Ofloxacin remains a highly prescribed fluoroquinolone due to its excellent bioavailability and broad-spectrum efficacy. The molecule is versatile and can be formulated into various dosage forms including tablets, oral suspensions, eye/ear drops, and intravenous infusions. Its established clinical profile makes it a staple in any comprehensive antibiotic portfolio.

This makes Ofloxacin one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators, hospital supply chains, and export-oriented companies globally.